Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Atkins

Showing results (231-240 of 304) with videos related to

Pageof 31
Sort By:
BMJ Open|December 31, 2025
Digital support for chronic dyspnoea management in primary care: protocol for the BREATHE (Breathlessness Rapid Evaluation and Therapy) cluster randomised controlled trialAllison Martin, Anthony Paulo Sunjaya, Katrina Giskes, et al.
Cell|May 31, 2016
Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBα DegradationXuan Zhao, Tsuyoshi Hirota, Xuemei Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2024
Targeting nuclear receptor corepressors for reversible male contraceptionSuk-Hyun Hong, Glenda Castro, Dan Wang, et al.
Brain, Behavior, and Immunity|June 9, 2019
The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophreniaJay P Nakamura, Anna Schroeder, Matthew Hudson, et al.
Nature|March 31, 2012
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-βHan Cho, Xuan Zhao, Megumi Hatori, et al.
Journal of Human Hypertension|May 14, 2024
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trialJoshua G Kovoor, Clara K Chow, Abdul Salam, et al.
Kidney International|June 15, 2007
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global OutcomesA S Levey, R Atkins, J Coresh, et al.
Lancet (London, England)|September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trialClara K Chow, Emily R Atkins, Graham S Hillis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2019
The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune diseaseChristina Chang, Chin-San Loo, Xuan Zhao, et al.
Heart, Lung & Circulation|May 2, 2021
Gender Comparison of Receipt of Government-Funded Health Services and Medication Prescriptions for the Management of Patients With Cardiovascular Disease in Primary CareNashid Hafiz, Karice Hyun, Andrew Knight, et al.
Pageof 31

Showing results (231-240 of 304) with videos related to

Sort By:
Pageof 31
BMJ Open|December 31, 2025
Digital support for chronic dyspnoea management in primary care: protocol for the BREATHE (Breathlessness Rapid Evaluation and Therapy) cluster randomised controlled trialAllison Martin, Anthony Paulo Sunjaya, Katrina Giskes, et al.
Cell|May 31, 2016
Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBα DegradationXuan Zhao, Tsuyoshi Hirota, Xuemei Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2024
Targeting nuclear receptor corepressors for reversible male contraceptionSuk-Hyun Hong, Glenda Castro, Dan Wang, et al.
Brain, Behavior, and Immunity|June 9, 2019
The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophreniaJay P Nakamura, Anna Schroeder, Matthew Hudson, et al.
Nature|March 31, 2012
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-βHan Cho, Xuan Zhao, Megumi Hatori, et al.
Journal of Human Hypertension|May 14, 2024
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trialJoshua G Kovoor, Clara K Chow, Abdul Salam, et al.
Kidney International|June 15, 2007
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global OutcomesA S Levey, R Atkins, J Coresh, et al.
Lancet (London, England)|September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trialClara K Chow, Emily R Atkins, Graham S Hillis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2019
The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune diseaseChristina Chang, Chin-San Loo, Xuan Zhao, et al.
Heart, Lung & Circulation|May 2, 2021
Gender Comparison of Receipt of Government-Funded Health Services and Medication Prescriptions for the Management of Patients With Cardiovascular Disease in Primary CareNashid Hafiz, Karice Hyun, Andrew Knight, et al.
Pageof 31